Sequence-selective DNA cleavage by a topoisomerase I poison, NB-506

International Journal of Cancer

Volumn 75, Issue 1, 1998, Pages 145-150

  Fukasawa, Kazuhiro ^a,b   Komatani, Hideyu ^a   Hara, Yoshikazu ^a   Suda, Hiroyuki ^a   Okura, Akira ^a   Nishimura, Susumu ^a   Yoshinari, Tomoko ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

^b Banyu Tskuba Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A][PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; DNA TOPOISOMERASE;

ARTICLE; DNA CLEAVAGE; DNA REPAIR; DNA SEQUENCE; DRUG DNA INTERACTION; DRUG EFFECT; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; CAMPTOTHECIN; CARBAZOLES; DNA; DNA REPAIR; DNA TOPOISOMERASES, TYPE I; GLUCOSIDES; MOLECULAR SEQUENCE DATA;

EID: 0032484531     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980105)75:1<145::AID-IJC22>3.0.CO;2-E     Document Type: Article

References (27)

1. ARAKAWA, H., IGEUCHI, T., MORIIA, M., YOSHINARI, T., KOJIRI, K., SUDA, H., OKURA, A. and NISHIMURA, S., Novel indolocarbazole compound 6-N- fortnylamino-12.13-dihydro-1.11- dihydroxy -13 (b-D-glucopyranoyl) -5H- indolo[2,3-a]pyrrol[3,4-c]carbazole-5,7(6H)-dionc (NB-506): its potent antitumor activities in mice. Cancer Res., 55, 1316-1320 (1995).
2. BAILLY, C., RIOV, J.F., COLSON, P., HOUSSIER, C., RODRIGUES-PEREIRA, E., and PRUDHOMME, M., DNA cleavage by topoisomerase I in the presence of indlocarbazole derivatives of reheccamycin. Biochemistry. 36, 3917-3929 (1997).
3. BEEN, M.D., BURGESS, R.R. and CHAMPOUX, J.J., Nucleotide sequence preference at rat liver and wheat germ type I DNA topoisomerase breakage sites in duplex SV40 DNA. Nucl. Acids Res., 12, 3097-3114 (1984).
4. BONVEN, B.J., GOCKE, E. and WESTERGAARD, O., A high affinity topoisomerase I binding sequence is clustered at DNAasc I hypersensitive sites in Tetrahymena r-chromalin. Cell, 41, 541-551 (1985).
5. CAPRANICO, G., BUTELLI, E. and ZUNINO, K. Change of the sequence specificity of daunorubicin-stimulatEd Topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety. Cancer Res., 55, 312-317 (1995).
6. CAPRANICO, G., PALUMBO, M., TINELLI, S., MABILIA, M., POZZAN, A. and ZUNINO, R. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage. J. mol. Biol., 235, 1218-1230 (1994).
7. CHAMWUX J.J., In: J.C. Wang and N.R. Cozarelli (eds.), DNA topology and its biological effects, pp. 217-242 Cold Spring Harbor Laboratory, NY (1990).
8. CHAMPOUX J.J. and ARONOFFR., The effect of camptoiheein on the reaction and the specificity of the wheat germ type I topoisomerase. J. Mol. Chem., 264, 1010-1015 (1989).
9. CMEN, A.Y. and LIU, L.F., DNA topoisomerases: essential enzyme and lethal targets. Ann. Rev. Pharmacol. Toxicol., 94, 194-218 (1994).
10. FOSSEÉ, P., RENÉ B., BRET, M.L., PAOLETTI, C. and SAUCIER, J.-M., Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by ellipticine derivative, Nucl, Acids Res., 19, 2861- 2868 (1991).
11. FUJII, N., YAMASHITA, Y., SAITOH, Y. and NAKANO, H., Induction of mammalian DNA topoisomerase I-mediatcd DNA cleavage and DNA winding by bulgarein. J. Mol. Chem., 268, 13160-13165 (1993).
12. HERTZBERG, R.P., BUSHY, R.W., CAKANFA, M.J., HOLDEN, K.G., JOHNSON, R.K., HECHT, S.M. and KINGSBURY, W.D., Irreversible trapping of the DNA-topoisomerase-I covalent complex. Affinity labeling of the camptothecin binding site. J. Biol. Chem., 265, 19287-19295 (1990).
13. HSIANG Y.H., LIU, L.F., WALL, M.K., WANI, M.C., NICHOLAS, A.W., MANIKUMAR, G., KIRSCHENBAUM, S., SILBER, R. and POTMESIC, M., DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camplothecin analogs. Cancer Res., 49, 4385-4389 (1989).
14. HUSAIN L., MOHLER, J.L., SEIGLER, H.F. and BUSTERMAN, J.M., Evaluation of topoisomerase I messenger RNA, protein and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res., 54, 539-546 (1994).
15. JANEL, C., CAPRANICO, G., KERRRIGAN, D., KOHN, K.W. and POMMIR, Y., Effect of local DNA sequence on topoisonierase I cleavage in the presence or absence of camplothecin, J. biol. Chem., 266, 20418-20423(1991).
16. JAXEL, C., KOHN, K.W. and POMMIER, Y., Topoisomerase I interaction with SV40 DNA in the presence anD absence of camptothecin. Nucl. Acids Res., 16, 11157-11170 (1988).
17. KJELDSEN, E., MOLLERUP, S., THOMSEN, B., BOVEN, B.J., BOLUND, L. and WESTERGAARD, O., Sequence-dependent effect of camplothecin on human topoisomerase I DNA cleavage. J. mol. Biol., 202, 333-342 (1988).
18. KJELDSEN, E., SVEISTRUP, J.Q., GROMOVA, I.I., ALSNER, J. and WESTER- GAARD, O., Camptothecin inhibits both the cleavage and religation reactions of eukuryotic DNA topoisomerase I. J. mol. Biol., 228, 1025-1030 (1992).
19. LETEURTRE, F., FESEN, M., KOHLHSGEN, G., KOHN, K.W. and POMMIER, Y., Specific interaction of camptothecin, a topoisomerase I inhibitor, with guanine residues of DNA detected by photoactivation at 365 nm. Biochemistry, 32, 8955-8962 (1993).
20. LETEURTE, F., FUJIMORI, A., TAMIZAWA, A.. CHHABRA, A., MAZUMDER, A., KOHLHAGEN, G., NAKANO, H. and POMMIER, Y., Saintpin, a dual inhibitor of DNA topoisomerase I and II. as a probe for drug-enzyme interactions. J. biol. Chem., 269, 28702-28707 (1994).
21. PORTER, S.F., and CHAMPOUX, J.J., Mapping in viva topoisomerase I sites on simian virus 40 DNA: asymmetric distribution of sites on replicating molecules. Mol. Cell. Biol., 9, 541-550 (1989).
22. SVEJSTRUP, J.Q., CHRISTIANSEN, K., ANDERSEN, A.M., LUND, K. and WESTER- GAARD, O., Minimal DNA duplex requirements for topoisomerase I- mediated cleavage in vitro. J. biol. Chem., 265, 12529-12535 (1990).
23. SVEJSTRUP, J.Q., CHRISTIANSEN, K., GROMOVA, I.I., ANDERSEN, A.M. and WESTERGAARD, O., New technique for uncoupling the cleavage and religation reaction of eukaryotic topoisomerase I. J. mol. Biol., 222, 669-678 (1991).
24. TANIZAWA, A., KOHN, K.W., KOHLHAGEN, G., LETEURTRE, F. and POMMIER, Y., Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. Biochemistry, 34, 7200-7206 (1995).
25. TANIZAWA, A., KOHN, K.W. and POMMIER, Y., Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin. Nucl. Acids Res., 21, 5157-5166 (1993).
26. YAMASHITA, Y., FUJII, N., MURAKATA, C., ASHIZAWA, T., OKABE, M. and NAKANO, H., Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives, Biochemistry 31, 12069-12075 (1992).
27. YOSHINAKI, T., MATSUMOTO, M., ARAKAWA, H., OKADA, H., NOGUCHI, K., SUDA, H., OKURA, A. and NISHIMURA, S., Novel antitumor indolocarbazole compound 6-N-formlamino-12,13-dihydro-1.11-dihydroxy-13 (b-D- glucopyranosyl)-5H-indolo[2,3]pyrrolo[3.4]carbazole-5,7(6H)-dione (NB- 506): induction of topoisomerase I-mediatcd DNA cleavage and mechanisms of cell line-selective cytotoxicity. Cancer Res., 55, 1310-1315 (1995).